Danuglipron Reconstitution Calculator
Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.
What amount do you need?
Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.
Syringe size:
Possible vial strengths:
Best Match
Good Match
Usable
Harder to Measure
Example Danuglipron Titration Schedule
| Parameter | Details |
|---|---|
| Dosage | 40 mg, 80 mg, 120 mg, or up to 200 mg per dose |
| Route | Oral (tablet) |
| Frequency | Twice daily (BID) |
| Cycle Length | 12–32 weeks in clinical trials |
| Half‑life | Not established (small molecule with rapid absorption) |
| Reconstitution | Not applicable; supplied as oral tablet |
| Food Effect | Can be dosed without regard to food |
Possible vial strengths:
What Is It?
Danuglipron
Oral small-molecule GLP-1 receptor agonist.
Bacteriostatic Water
Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.
How To Mix Danuglipron
1
CleanUse alcohol swabs to clean the tops of both vials.
2
Draw BAC WaterDraw the selected amount of bacteriostatic water.
3
Inject SlowlyAdd the liquid slowly down the side of the vial.
4
Swirl GentlyDo not shake. Swirl gently until dissolved.
5
Store ProperlyStore as directed and protect from heat and light.
Best Practices & Common Mistakes
Best Practices
- Use sterile technique.
- Protect from light and heat.
- Store refrigerated when appropriate.
- Use clean syringe-unit math before measuring.
Common Mistakes
- Confusing milligrams with milliliters.
- Choosing an option with awkward decimal units.
- Using too little liquid for very small measurements.
- Shaking the vial aggressively.
Danuglipron Storage & Handling
Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Frequently Asked Questions
No. Danuglipron is a small‑molecule GLP-1 agonist, not a peptide. BAC water will not work. For oral research, use a homogeneous suspension in 0.5% CMC‑Na. For injection, follow the validated vehicle: 5% DMSO → 40% PEG300 → 5% Tween‑80 → 50% ddH₂O.
Danuglipron has a short half‑life (~2.4 h in rats; ~1 h in monkeys), requiring twice‑daily (BID) oral administration to maintain effective levels. Phase 2b trials dosed BID at 10–12 h intervals. A once‑daily schedule will under‑dose.
The titration schedule is mandatory, not optional. Phase 2 trials used fixed 1‑, 2‑, or 4‑week escalation steps, with starting doses of 5 mg or 10 mg BID, gradually increasing to 40–200 mg BID. Skipping escalation increases discontinuations due to GI events.
Danuglipron has the highest GI burden among oral GLP‑1 agonists. In Phase 2b, 73% nausea, 47% vomiting, 25% diarrhea. High discontinuation rates (>50%) were observed across all doses, with up to 72.7% discontinuing in some groups. Plan tolerance management carefully.
Lyophilised powder is stable for 36 months at –20 °C. For stock solutions, use DMSO and store at –20 °C for ≤1 month, or –80 °C for ≤6 months. Always aliquot immediately after preparation to prevent repeated freeze‑thaw cycles.
Practical takeaway: If your real goal is weight or metabolic health, the most useful next step is discussing approved treatment options with a clinician rather than relying on an unapproved compound.
Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.